AS
Akanksha Singh Gaur
About Akanksha Singh Gaur
Data last updated:
Akanksha Singh Gaur is a Director at Vmvs Nexgen Pharmarise India Private Limited (since 2021). The company operates in Chemicals. Vmvs Nexgen Pharmarise India Private Limited reported revenue of ₹37.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Nov 2021 | 2021 | ₹37.7 Lakh (FY 2025) | Active |
Board colleagues of Akanksha Singh Gaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepti Srivastava | 09394894 | Vmvs Nexgen Pharmarise India Private Limited | Director |
| Vivek Singh | 09401156 | Vmvs Nexgen Pharmarise India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akanksha Singh Gaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akanksha Singh Gaur
Akanksha Singh Gaur currently holds 1 directorship: Vmvs Nexgen Pharmarise India Private Limited (Director, since 16 Nov 2021, revenue ₹37.7 Lakh (FY 2025)).
Akanksha Singh Gaur was first appointed on 16 Nov 2021 as Director at Vmvs Nexgen Pharmarise India Private Limited.
The current boards of Akanksha Singh Gaur's companies include Deepti Srivastava (Vmvs Nexgen Pharmarise India Private Limited), Vivek Singh (Vmvs Nexgen Pharmarise India Private Limited).